Marianne Schmidt

Summary

Country: Germany

Publications

  1. ncbi Suicide gene therapy in head and neck carcinoma cells: an in vitro study
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wuerzburg, Josef Schneider Strasse 11, Wurzburg, Germany
    Int J Mol Med 27:591-7. 2011
  2. ncbi The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wurzburg, D 97080 Wurzburg, Germany
    Oncol Rep 21:1297-305. 2009
  3. ncbi Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wurzburg, Josef Schneider Strasse 11, 97080, Wurzburg, Germany
    Eur Arch Otorhinolaryngol 263:127-34. 2006
  4. ncbi Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wurzburg, Josef Schneider Strasse 11, D 97080 Wurzburg, Germany
    Otol Neurotol 23:267-70. 2002
  5. ncbi Inducible promoters for gene therapy of head and neck cancer: an in vitro study
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wurzburg, Josef Schneider Strasse 11, 97080 Wurzburg, Germany
    Eur Arch Otorhinolaryngol 261:208-15. 2004

Detail Information

Publications5

  1. ncbi Suicide gene therapy in head and neck carcinoma cells: an in vitro study
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wuerzburg, Josef Schneider Strasse 11, Wurzburg, Germany
    Int J Mol Med 27:591-7. 2011
    ..Our in vitro study revealed that the use of toxin genes in combination with the GeneSwitch system is a promising approach for gene therapy in head and neck cancer...
  2. ncbi The effects of PC-Spes on chemosensitive and chemoresistant head and neck cancer cells and primary mucosal keratinocytes
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wurzburg, D 97080 Wurzburg, Germany
    Oncol Rep 21:1297-305. 2009
    ..PC-Spes might therefore provide a therapeutical approach in chemoresistant head and neck cancer...
  3. ncbi Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wurzburg, Josef Schneider Strasse 11, 97080, Wurzburg, Germany
    Eur Arch Otorhinolaryngol 263:127-34. 2006
    ..Furthermore, western blots showed an overexpression of MDR-1 in the taxol-resistant clone, while alpha- and beta-tubulins and p48/IRF9 were expressed in equal amounts in both cell lines...
  4. ncbi Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wurzburg, Josef Schneider Strasse 11, D 97080 Wurzburg, Germany
    Otol Neurotol 23:267-70. 2002
    ..The aim of the study was to evaluate the role of bone morphogenetic protein-2 (BMP-2) in the pathology of middle ear cholesteatoma...
  5. ncbi Inducible promoters for gene therapy of head and neck cancer: an in vitro study
    Marianne Schmidt
    Department of Otorhinolaryngology, University of Wurzburg, Josef Schneider Strasse 11, 97080 Wurzburg, Germany
    Eur Arch Otorhinolaryngol 261:208-15. 2004
    ..Both systems worked in a highly cell-type dependent manner. The possible clinical use of externally inducible transgene expression in head and neck carcinoma gene therapy is critically discussed...